Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Health-care medicine composition

A composition and drug technology, applied in the directions of drug combination, drug delivery, hydrocarbon compound active ingredients, etc., can solve the problems affecting the curative effect and application scope, etc., to prevent liver cell degeneration, reduce damage, and inhibit the production of peroxides Effect

Inactive Publication Date: 2016-05-04
天津中津药业股份有限公司
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, most of the current glutathione drugs are single preparations, which affect their curative effect and application range. It is urgent to provide a compound glutathione preparation with high curative effect, wide application and safety, so as to fully play the role of glutathione in human diseases. Medical value in the treatment and prevention of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] A medicine and health care composition tablet, the composition includes by mass parts: glutathione 350, silymarin 120, earwort extract 60, Herba officinalis extract 40, cicada flower extract 20 and necessary Accessories.

[0063] Pass the main ingredients glutathione, silymarin, eargrass extract, vermicelli officinale extract and cicada flower extract through a 100-mesh sieve, excipients: starch, dextrin, lactose, xylitol, magnesium stearate, Both polyvidone and povidone K30 are passed through a 80-mesh sieve, and the main and auxiliary materials are put into a mixer and stirred with purified water for 6 minutes to make a soft material. The soft material is passed through a 16-mesh sieve to make wet granules, and the wet granules are boiled at 80 degrees Dry, put in a mixer and mix thoroughly for 12 minutes, pass the mixed granules through a 18-mesh sieve, and press into tablets.

Embodiment 2

[0065] A pharmaceutical health care composition hard capsule, the composition includes by mass parts: glutathione 180, silymarin 90, earwort extract 20, Herba officinalis extract 30, cicada flower extract 20 and necessary Accessories.

[0066] Pass glutathione, silymarin, eargrass extract, Herba officinalis extract and cicada flower extract through a 60-mesh sieve, and cross-linked povidone and povidone K30 through a 60-mesh sieve, and mix with Tween- 80 was put into the mixer and stirred for 15 minutes to make the material evenly stirred, then granulated, dried and mixed, passed through a 20-mesh sieve, and then filled.

Embodiment 3

[0068] A pharmaceutical and health care composition soft capsule, the composition includes in parts by mass: glutathione 220, silymarin 150, ear grass extract 50, Herba Vernix extract 40, cicada flower extract 20 and necessary Accessories.

[0069] Pass glutathione, silymarin, eargrass extract, vermicelli officinale extract and cicada flower extract through a 40-mesh sieve, auxiliary materials: PEG-400, vegetable oil, glycerin, cyclodextrin, sorbitol, put the main auxiliary materials into Fully stir in the mixer for 25 minutes to make the material evenly stirred before filling.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a health-care medicine composition. The composition is prepared from, by mass, 60-600 parts of glutathione, 50-300 parts of silymarin, 1-100 parts of auricled hedyotis herb extracts, 1-100 parts of potentilla disclor bunge extracts, 1-100 parts of cordyceps cicadae extracts and auxiliary materials. The composition comprises, by mass, one or more of 50-200 parts of vitamin C, 50-200 parts of vitamin E, 100-300 parts of astaxanthin, 100-300 parts of lycopene, 100-300 parts of xanthophylls, 100-300 parts of beta-carotene, 100-300 parts of grape seed extracts, 100-300 parts of anthocyanin, 100-300 parts of ganoderma spore powder, 200-1000 of coenzyme Q10 and 200-1500 parts of garlic essence oil. The composition has the functions of clearing away toxin, treating radiation diseases, carrying out radiation protection, protecting the liver, enhancing immunity, improving the disease course and symptoms of some diseases, resisting allergy, beautifying faces, nourishing skin, improving eyesight, treating eye diseases, resisting aging and the like.

Description

technical field [0001] The invention relates to a composition, in particular to a medicine and health care composition. Background technique [0002] Glutathione (GSH) is a tripeptide that combines glutamic acid, cysteine ​​and glycine and contains a sulfhydryl group, and has antioxidant and integrated detoxification effects. The sulfhydryl group on cysteine ​​is the active group of glutathione, which is easy to combine with certain drugs (such as paracetamol), toxins (such as free radicals, iodoacetic acid, mustard gas, lead, mercury, arsenic and other heavy metals), and has Integrate detoxification. Therefore, glutathione (especially glutathione in liver cells) can participate in biotransformation, thereby converting harmful poisons in the body into harmless substances and excreting them out of the body. [0003] Excessive free radicals produced by the body's metabolism can damage biofilms, invade life macromolecules, accelerate body aging, and induce tumors or atheroscl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/06A61P17/00A61P17/16A61P1/16A61P31/14A61P31/20A61P27/02A61P37/04A61P39/06A61P37/08A61P39/02A61P25/00A61P13/12A61P3/10A61K31/357A61K36/87A61K36/748A61K36/8962A61K31/01A61K31/122A61K31/015A61K31/355A61K31/375A61K31/047A61K35/64
CPCA61K38/06A61K9/0053A61K9/08A61K9/2059A61K9/4866A61K31/01A61K31/015A61K31/047A61K31/122A61K31/355A61K31/357A61K31/375A61K36/066A61K36/074A61K36/73A61K36/748A61K36/87A61K36/8962A61K47/26A61K2300/00
Inventor 宋富智梁世昌王培松
Owner 天津中津药业股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com